Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets

Lee's Pharmaceutical Holdings Limited, through its subsidiary Nova Pneuma Inc., acquires the Staccato® One Breath Technology® platform and related assets from Alexza Pharmaceuticals, including intellectual property, trademarks, product pipeline, equipment, and manufacturing rights for Staccato® alprazolam under a global partnership with UCB.